Growth leaders identify and evaluate targets and opportunities using multiple sources. One common strategy is to target contract recompetes and those which are potentially vulnerable, with a primary vulnerability being contracts held by companies that have been acquired, especially when they are a small business being acquired by a large.
Case in point – Over the past 6 months, the OS AI team has fielded several requests looking to better understand a string of recent acquisitions made by one equity backed large digital transformation services large business. A primary focus centered around the contracts that a now acquired small business, that specializes in data science and engineering services to the federal civilian and healthcare communities held, with an emphasis on its Food and Drug Administration portfolio.
We should note that being acquired does not always make a company’s contracts inherently vulnerable as there are many factors in play but in the interest of sharing, included below we share details about a handful of relevant expiring contracts from across the federal civilian sector that have been drawing some attention, to include one potential $100M+ FDA BPA contract.